These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37768837)
1. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia. Arndt G; Wai R; Stiel H J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837 [TBL] [Abstract][Full Text] [Related]
2. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options. Flanagan BA; Collins C; Parra S Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728 [TBL] [Abstract][Full Text] [Related]
3. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study. Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneous tranexamic acid for bleeding associated with a mycotic aortic aneurysm. Kilpatrick M; Bateman S; Baggott A; Sutherland A BMJ Support Palliat Care; 2024 Aug; 14(3):303-304. PubMed ID: 37094882 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid]. Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis]. Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479 [No Abstract] [Full Text] [Related]
8. Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report. Kiyeng JC; Siika A; Koech C; Bloomfield GS J Med Case Rep; 2016 May; 10(1):126. PubMed ID: 27225226 [TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H; J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799 [TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis. Lacout A; Marcy PY; El Hajjam M; Lacombe P Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075 [No Abstract] [Full Text] [Related]
11. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Sabbà C; Gallitelli M; Palasciano G N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536 [No Abstract] [Full Text] [Related]
13. Tranexamic acid in hereditary hemorrhagic telangiectasia. Lozano M N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543 [No Abstract] [Full Text] [Related]
14. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Klepfish A; Berrebi A; Schattner A Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712 [No Abstract] [Full Text] [Related]
15. Tranexamic acid-bevacizumab synergy in HHT patients presenting pulmonary arteriovenous malformations. Lacout A; Marcy PY; El Hajjam M; Lacombe P Med Hypotheses; 2012 Nov; 79(5):605-6. PubMed ID: 22959314 [TBL] [Abstract][Full Text] [Related]
16. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis. Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816 [TBL] [Abstract][Full Text] [Related]
17. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care. Al-Samkari H Blood; 2021 Feb; 137(7):888-895. PubMed ID: 33171488 [TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia. Fujimori S World J Gastroenterol; 2023 Feb; 29(7):1131-1138. PubMed ID: 36926669 [TBL] [Abstract][Full Text] [Related]
19. Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis. Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K Curr Allergy Asthma Rep; 2023 Dec; 23(12):689-701. PubMed ID: 37995018 [TBL] [Abstract][Full Text] [Related]
20. Hereditary haemorrhagic telangiectasia with protein S deficiency in a family: a case report. Wechalekar A; Parapia L Eur J Haematol; 2000 Jan; 64(1):59-60. PubMed ID: 10680707 [No Abstract] [Full Text] [Related] [Next] [New Search]